RAM
KALA icon

Readystate Asset Management’s KALA BIO KALA Stock Holding History

Readystate Asset Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-849
Closed -$243K – 781
2025
Q1 		$243K Buy
+849
New +$321K 0.01% 556

Other funds holding KALA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Readystate Asset Management's KALA Position: Q2 2025 in Review

Readystate Asset Management sold out of KALA BIO (KALA) in Q2 2025, closing a stake of 849 shares — an estimated $243K sold.

Readystate Asset Management first reported a position in KALA in Q1 2025 and held it in 1 quarter. The position peaked at $243K in Q1 2025. 27 funds tracked by Wall St. Rank hold KALA as of Q2 2025.

  • Readystate Asset Management reported no remaining KALA BIO position as of Q2 2025 after selling out during the quarter.
  • Readystate Asset Management sold 849 KALA BIO shares in Q2 2025, an estimated $243K.
  • Readystate Asset Management first reported a position in KALA BIO in Q1 2025 and held it in 1 quarter.
  • Readystate Asset Management's KALA BIO position peaked at $243K in Q1 2025.
  • 27 funds tracked by Wall St. Rank held KALA BIO as of Q2 2025.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.